Skip to content

High-resolution CE-MRA of Children's Hip Joint

High-resolution Contrast-enhanced Magnetic Mesonance Angiography of Children's Hip Joint

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05754905
Enrollment
48
Registered
2023-03-06
Start date
2021-01-01
Completion date
2023-01-31
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip, Magnetic Resonance, Three-dimensional Water-selective Cartilage (3D-WATSc), Vessels; Anomaly

Brief summary

The goal of this observational study is to learn about the feasibility of enhanced three-dimensional water-selective cartilage (3D-WATSc) sequence in displaying the vessels of children's hip by magnetic resonance. The main questions it aims to answer are: * Could the images of enhanced 3D-WATSc sequence show the healthy side hip joint vessels in children? * Could the images of enhanced 3D-WATSc sequence show the vascular disease of the suffering side hip joint in children? Participants with unilateral hip disease will undergo the magnetic resonance examination including enhanced 3D-WATSc sequence. The pelvic plain film and magnetic resonance images will be collected and analysed. Researchers will compare the images of of the normal side with the images of the abnormal side to see if the enhanced 3D-WATSc sequence images could show the vascular disease of the suffering side hip joint in children?

Interventions

the two groups are underwent magnetic resonance examination including enhanced 3D-WATSc sequence

Sponsors

Children's Hospital of Chongqing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 14 Years

Inclusion criteria

* Children aged 6 months-14 years who are diagnosed as hip disease after screening by pediatric orthopedic surgeon in Children's Hospital of Chongqing Medical University during the study period. The hip disease contain developmental dysplasia of the hip, Perthes disease, infection of the hip, inflammation of the hip, fracture of the hip, and Meyer's dysplasia.

Exclusion criteria

* patients with bilateral hip joint disease; patients with claustrophobia;Patients with metal implants (such as pacemaker implantation)

Design outcomes

Primary

MeasureTime frameDescription
The medial circumflex femoral artery (MCFA) and lateral circumflex femoral artery (LCFA) of the bilateral hip joint1 day (Magnetic resonance examination end time)Morphology of the MCFA and LCFA of the bilateral hip joint
The branches of the MCFA and/or LCFA around the bilateral femoral neck1 day (Magnetic resonance examination end time)Morphology of MCFA and/or LCFA branches around the bilateral femoral neck
The vessels of secondary ossification center and/or cartilaginous vascular canal in bilateral femoral head1 day (Magnetic resonance examination end time)Morphology of the vessels and cartilaginous vascular canal in bilateral femoral head

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026